Affordable Access

deepdyve-link
Publisher Website

MS-based targeted metabolomics of eicosanoids and other oxylipins: Analytical and inter-individual variabilities.

Authors
  • Gladine, Cécile1
  • Ostermann, Annika I2
  • Newman, John W3
  • Schebb, Nils Helge2
  • 1 Université Clermont Auvergne, INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, Clermont-Ferrand, France. Electronic address: [email protected] , (France)
  • 2 Chair of Food Chemistry, Faculty of Mathematics and Natural Sciences, Gaußstraße 20, University of Wuppertal, 42119, Wuppertal, Germany. , (Germany)
  • 3 United States Department of Agriculture, Agricultural Research Service, Western Human Nutrition Research Center, Davis, CA, USA; University of California Davis, Department of Nutrition, Davis, CA, USA. , (United States)
Type
Published Article
Journal
Free radical biology & medicine
Publication Date
Nov 20, 2019
Volume
144
Pages
72–89
Identifiers
DOI: 10.1016/j.freeradbiomed.2019.05.012
PMID: 31085232
Source
Medline
Language
English
License
Unknown

Abstract

Oxylipins, including the well-known eicosanoids, are potent lipid mediators involved in numerous physiological and pathological processes. Therefore, their quantitative profiling has gained a lot of attention during the last years notably in the active field of health biomarker discovery. Oxylipins include hundreds of structurally and stereochemically distinct lipid species which today are most commonly analyzed by (ultra) high performance liquid chromatography-mass spectrometry based ((U)HPLC-MS) methods. To maximize the utility of oxylipin profiling in clinical research, it is crucial to understand and assess the factors contributing to the analytical and biological variability of oxylipin profiles in humans. In this review, these factors and their impacts are summarized and discussed, providing a framework for recommendations expected to enhance the interlaboratory comparability and biological interpretation of oxylipin profiling in clinical research. Copyright © 2019 Elsevier Inc. All rights reserved.

Report this publication

Statistics

Seen <100 times